Signees of the letter include executives from Aetna, Anthem and Cigna. The insurers, which collectively cover about 248 million people, endorsed eight basic principles — developed by the nonprofit Shatterproof — to help improve healthcare outcomes for people with substance use disorders. They also plan to leverage their purchasing power to reward proven, evidence-based treatments for addiction.
“This is the first step toward a clear, measurable solution,” said Thomas McLellan, PhD, former deputy director of the Office of National Drug Control Policy and a scientific advisor to Shatterproof, according to NJ Spotlight. “It can honestly be said that now with proper treatment, recovery is an expectable outcome.”
The care principles endorsed by the insurers include universal screening for substance use disorders across medical settings, access to medication-assisted treatments for addiction and access to fully trained behavioral health professionals, among other standards.
More articles on opioids:
New York state physician indicted on charges linked to 6 opioid overdose deaths
Study: OTC painkillers as effective as opioids in the ED
28 Wisconsin counties file opioid lawsuits against drugmakers, physicians
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
